Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implications for seizure susceptibility

Neuroscience

Volumn 161, Issue 1, 2009, Pages 293-300

  Balosso, S ^a   Ravizza, T ^a   Pierucci, M ^a   Calcagno, E ^a   Invernizzi, R ^a   Di Giovanni, G ^a   Esposito, E ^a   Vezzani, A ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

AMPA; astrocytes; cytokines; inflammation; kainate receptors; NMDA

Indexed keywords

AMPA RECEPTOR; CYTOKINE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 6; GLUTAMATE RECEPTOR 7; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN P75; PROTEIN SUBUNIT; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SEIZURE SUSCEPTIBILITY; SIGNAL TRANSDUCTION;

ACTION POTENTIALS; ANIMALS; DISEASE SUSCEPTIBILITY; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; NEURONS; PROTEIN SUBUNITS; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEIZURES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349130798     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.005     Document Type: Article

References (62)

1. Albensi B.C., and Mattson M.P. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35 (2000) 151-159
2. Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2 (2001) 734-744
3. Balosso S., Ravizza T., Perego C., Peschon J., Campbell I.L., De Simoni M.G., and Vezzani A. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 57 (2005) 804-812
4. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., and Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 295 (2002) 2282-2285
5. Bendotti C., Tortarolo M., Suchak S.K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., and Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79 (2001) 737-746
6. Bette M., Kaut O., Schafer M.K., and Weihe E. Constitutive expression of p55TNFR mRNA and mitogen-specific up-regulation of TNF alpha and p75TNFR mRNA in mouse brain. J Comp Neurol 465 (2003) 417-430
7. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4 (2001) 702-710
8. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2 (1996) 788-794
9. Butler M.P., O'Connor J.J., and Moynagh P.N. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124 (2004) 319-326
10. Ceglia I., Carli M., Baviera M., Renoldi G., Calcagno E., and Invernizzi R.W. The 5-HT receptor antagonist M100907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 91 (2004) 189-199
11. Chao C.C., Hu S., Ehrlich L., and Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9 (1995) 335-365
12. Chapman A.G., Woodburn V.L., Woodruff G.N., and Meldrum B.S. Anticonvulsant effect of reduced NMDA receptor expression in audiogenic DBA/2 mice. Epilepsy Res 26 (1996) 25-35
13. Cull-Candy S.G., and Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 255 (2004) re16
14. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., and O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203 (1996) 17-20
15. Del Arco A., Segovia G., Fuxe K., and Mora F. Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions?. J Neurochem 85 (2003) 23-33
16. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., and Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12 (2000) 2623-2633
17. Donzanti B.A., and Yamamoto B.K. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 43 (1988) 913-922
18. Fellin T., Gomez-Gonzalo M., Gobbo S., Carmignoto G., and Haydon P.G. Astrocytic glutamate is not necessary for the generation of epileptiform neuronal activity in hippocampal slices. J Neurol Sci 26 (2006) 9312-9322
19. Ferguson A.R., Christensen R.N., Gensel J.C., Miller B.A., Sun F., Beattie E.C., Bresnahan J.C., and Beattie M.S. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurol Sci 28 (2008) 11391-11400
20. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (1997), Academic Press, San Diego
21. Furukawa K., and Mattson M.P. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J Neurochem 70 (1998) 1876-1886
22. Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., and Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurol Sci 28 (2008) 6904-6913
23. Ghezzi P., and Mennini T. Tumor necrosis factor and motoneuronal degeneration: an open problem. Neuroimmunomodulation 9 (2001) 178-182
24. Gimenez F., Barraud de Lagerie S., Fernandez C., Pino P., and Mazier D. Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 60 (2003) 1623-1635
25. Isaac J.T., Ashby M., and McBain C.J. The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 54 (2007) 859-871
26. Kuno R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., Kawanokuchi J., Takeuchi H., Mizuno T., and Suzumura A. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res 1116 (2006) 12-18
27. Leonoudakis D., Braithwaite S.P., Beattie M.S., and Beattie E.C. TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?. Neuron Glia Biol 1 (2004) 263-273
28. Levite M., and Ganor Y. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert Rev Neurother 8 (2008) 1141-1160
29. Lu M.O., Zhang X.M., Mix E., Quezada H.C., Jin T., Zhu J., and Adem A. TNF-alpha receptor 1 deficiency enhances kainic acid-induced hippocampal injury in mice. J Neurol Sci Res 86 (2008) 1608-1614
30. MacEwan D.J. TNF ligands and receptors-a matter of life and death. Br J Pharmacol 135 (2002) 855-875
31. Meli D.N., Loeffler J.M., Baumann P., Neumann U., Buhl T., Leppert D., and Leib S.L. In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J Neuroimmunol 151 (2004) 6-11
32. Mulle C., Sailer A., Perez-Otano I., Dickinson-Anson H., Castillo P.E., Bureau I., Maron C., Gage F.H., Mann J.R., Bettler B., and Heinemann S.F. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392 (1998) 601-605
33. Munoz-Fernandez M.A., and Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56 (1998) 307-340
34. Nadeau S., and Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93 (1999) 1449-1464
35. 2+-permaeble alpha-amino-3-hydroxil-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp Neurol 193 (2005) 384-393
36. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., and Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160 (1998) 943-952
37. Pickering M., and O'Connor J.J. Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res 163 (2007) 339-354
38. 2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology 42 (2002) 93-106
39. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., and Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol 72 (1997) 137-141
40. Riazi K., Galic M.A., Kuzmiski J.B., Ho W., Sharkey K.A., and Pittman Q.J. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 105 (2008) 17151-17156
41. Robinson T.E., and Whishaw I.Q. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450 (1988) 209-224
42. Rogers S.W., Andrews P.I., Gahring L.C., Whisenand T., Cauley K., Crain B., Hughes T.E., Heinemann S.F., and McNamara J.O. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265 (1994) 648-651
43. Saha R.N., and Pahan K. Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem 86 (2003) 1057-1071
44. Sairanen T., Carpen O., Karjalainen-Lindsberg M.L., Paetau A., Turpeinen U., Kaste M., and Lindsberg P.J. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 32 (2001) 1750-1758
45. Shandra A.A., Godlevsky L.S., Vastyanov R.S., Oleinik A.A., Konovalenko V.L., Rapoport E.N., and Korobka N.N. The role of TNF-alpha in amygdala kindled rats. Neurosci Res 42 (2002) 147-153
46. Shinoda S., Skradski S.L., Araki T., Schindler C.K., Meller R., Lan J.Q., Taki W., Simon R.P., and Henshall D.C. Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci 17 (2003) 2065-2076
47. Sriram K., and O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2 (2007) 140-153
48. Stellwagen D., Beattie E.C., Seo J.Y., and Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurol Sci 25 (2005) 3219-3228
49. Stellwagen D., and Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 440 (2006) 1054-1059
50. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., and Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281 (2006) 21362-21368
51. Tancredi V., D'Arcangelo G., Grassi F., Tarroni P., Palmieri G., Santoni A., and Eusebi F. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146 (1992) 176-178
52. Tansey M.G., McCoy M.K., and Frank-Cannon T.C. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 1 (2007) 1-25
53. Telfeian A.E., Federoff H.J., Leone P., During M.J., and Williamson A. Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro. Neurobiol Dis 7 (2000) 362-374
54. Thommesen L., and Laegreid A. Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB. J Biochem Mol Biol 38 (2005) 281-289
55. van der Zeyden M., Oldenziel W.H., Rea K., Cremers T.I., and Westerink B.H. Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors. Pharmacol Biochem Behav 90 (2008) 135-147
56. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
57. Vincent P., and Mulle C. Kainate receptors in epilepsy and excitotoxicity. Neuroscience 158 (2008) 309-323
58. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di L.M., Galli C.L., and Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurol Sci 23 (2003) 8692-8700
59. Viviani B., Gardoni F., and Marinovich M. Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82 (2007) 247-263
60. Yuhas Y., Weizman A., and Ashkenazi S. Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures. Infect Immun 71 (2003) 2288-2291
61. Zapata A., Capdevila J.L., Tarrason G., Adan J., Martinez J.M., Piulats J., and Trullas R. Effects of NMDA-R1 antisense oligodeoxynucleotide administration: behavioral and radioligand binding studies. Brain Res 745 (1997) 114-120
62. Zou J.Y., and Crews F.T. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res 1034 (2005) 11-24